Panel recommends Serum Institute's name for phase 2, 3 human clinical trials of Oxford vaccine candidate
The recommendations of the committee at the Central Drugs Standard
Control Organisation have been sent to the Drugs Controller General of
India for approval.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/panel-recommends-serum-institutes-name-for-phase-2-3-human-clinical-trials-of-oxford-vaccine-candidate/articleshow/77287839.cms
Control Organisation have been sent to the Drugs Controller General of
India for approval.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/panel-recommends-serum-institutes-name-for-phase-2-3-human-clinical-trials-of-oxford-vaccine-candidate/articleshow/77287839.cms
Comments
Post a Comment